The 1995 Walter Hubert Lecture - Molecular Epidemiology of Human Cancer: Insights from the Mutational Analysis of the p53 Tumour-Suppressor Gene
1996
Molecular Epidemiology of Human Cancer: Insights from p53 Gene Analysis
publication
Evidence: moderate
Author Information
Author(s): CC Harris
Primary Institution: Laboratory of Human Carcinogenesis, National Cancer Institute, NIH
Hypothesis
Can the mutational analysis of the p53 tumour-suppressor gene improve cancer risk assessment?
Conclusion
The study highlights the importance of p53 mutations in understanding cancer risk and the implications for public health.
Supporting Evidence
- The p53 gene is frequently mutated in many human cancers, indicating its role in cancer development.
- High-risk inherited conditions related to p53 mutations can significantly increase cancer risk.
- Understanding p53 mutations can help in developing public health policies for genetic screening.
Takeaway
Scientists are studying a gene called p53 to understand how it can help predict who might get cancer, which can help keep people safe.
Methodology
The study reviews molecular epidemiology and mutational analysis of the p53 gene in relation to cancer risk.
Limitations
The study acknowledges the challenges in assessing individual cancer risk and the bioethical dilemmas involved.
Want to read the original?
Access the complete publication on the publisher's website